scholarly article | Q13442814 |
P50 | author | John Kjekshus | Q6243255 |
Anne G Semb | Q89845760 | ||
Torbjørn Holm | Q114371002 | ||
Ragnhild Wergeland | Q114371011 | ||
Aina Hognestad | Q114371041 | ||
Pål Aukrust | Q47504859 | ||
Lars Gullestad | Q63256598 | ||
P2093 | author name string | Arne K Andreassen | |
Oddvar Stokke | |||
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era | Q73386862 | ||
Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation | Q74207496 | ||
Effect of atorvastatin on plasma fibrinogen | Q74282353 | ||
[Regulation of endothelial NO production by Rho GTPase] | Q77896366 | ||
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease | Q28181305 | ||
Levels of soluble cell adhesion molecules in patients with dyslipidemia | Q28279951 | ||
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells | Q28379577 | ||
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia. | Q32007717 | ||
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? | Q33678964 | ||
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction | Q33883883 | ||
Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels | Q33942737 | ||
Non-lipid-lowering effects of statins on atherosclerosis | Q34027314 | ||
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I. | Q34429041 | ||
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia | Q34439645 | ||
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway | Q39946864 | ||
A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study | Q40818460 | ||
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction | Q40857092 | ||
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease | Q40868032 | ||
Statins do more than just lower cholesterol | Q41169571 | ||
Vascular effects of statins in stroke | Q41642213 | ||
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects | Q43601429 | ||
PRINCE's prospects: statins, inflammation, and coronary risk | Q43619566 | ||
Effects of simvastatin and atorvastatin on inflammation markers in plasma | Q43959187 | ||
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events | Q44216708 | ||
Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors | Q48434703 | ||
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia. | Q51581527 | ||
Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia | Q58421218 | ||
Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans | Q71971748 | ||
C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction | Q71971756 | ||
Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia | Q72595264 | ||
Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month | Q73120271 | ||
P433 | issue | 4 | |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 199-203 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Clinical Cardiology | Q4502312 |
P1476 | title | Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation | |
P478 | volume | 27 |
Q43109248 | Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis |
Q83940492 | Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease |
Q33802886 | Association of statin use with cognitive decline in elderly African Americans |
Q28174014 | Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study |
Q46806024 | Enhanced acetylcholine-induced dilation in afferent arterioles in simvastatin-fed rats |
Q42133595 | Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome |
Q33904404 | Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study |
Q34769971 | Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial |
Q42949809 | Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia |
Q36836591 | Statins and blood pressure: is there an effect or not? |
Q38029526 | The antihypertensive actions of statins: modulation by salt intake |
Q35880875 | The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress |
Search more.